Tech Company Financing Transactions
Cardax Pharmaceuticals Funding Round
Private investors joined a $2.1 million funding round for Cardax Pharmaceuticals. The financing round was announced on 1/20/2014.
Transaction Overview
Company Name
Announced On
1/20/2014
Transaction Type
Debt
Amount
$2,076,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2800 Woodlawn Dr. 129
Honolulu, HI 96822
USA
Honolulu, HI 96822
USA
Phone
Website
Email Address
Overview
Cardax, Inc. is developing orally bioavailable anti-inflammatory compounds with robust safety for major unmet medical needs. $CDXI
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Watumull
Chief Financial Officer
John Russell
Chief Operating Officer
David Watumull
Chief Scientific Officer
Gilbert Rishton
VP - R & D
Timothy King
Browse more venture capital transactions:
Prev: 1/20/2014: 5i Sciences venture capital transaction
Next: 1/20/2014: GiveGab venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs